Synaptophysin (syp I) is a synaptic vesicle membrane protein that constitutes -7% of the total vesicle protein. Multiple lines of evidence implicate syp I in a number of nerve terminal functions. To test these, we have disrupted the murine syp I gene. Mutant mice lacking syp I were viable and fertile. No changes in the structure and protein composition of the mutant brains were observed except for a decrease in synaptobrevin/VAMP II. Synaptic transmission was normal with no detectable changes in synaptic plasticity or the probability of release. Our data demonstrate that one of the major synaptic vesicle membrane proteins is not essential for synaptic transmission, suggesting that its function is either redundant or that it has a more subtle function not apparent in the assays used.
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Synaptophysin (syp I) constitutes an abundant synaptic vesicle membrane protein that contains four transmembrane regions (1) (2) (3) (4) . Syp I .forms a high molecular weight complex in the vesicle membrane containing at least four syp I subunits and a low molecular protein of 18 kDa (5) recently identified as synaptobrevin/VAMP (6, 7) . Syp I is phosphorylated on its cytoplasmic C-terminus by both serine/threonine and tyrosine kinases (8) (9) (10) . In the mature nerve terminal it represents one of the major proteins carrying phosphotyrosine (11) .
In addition to syp I, synaptic vesicles contain a highly homologous membrane protein named synaptoporin or synaptophysin II (syp II) (12) . Syp I and syp II exhibit distinct distributions in brain: Syp I is ubiquitously expressed and present in virtually all synapses whereas syp II is expressed at high levels only in selected neurons, suggesting that syp II has a more specialized function (13, 14) . In the hippocampus, high levels of syp II are detected in mossy fiber terminals, with other synapses containing much lower amounts. Although syp II exhibits a heteromultimeric subunit structure similar to that of syp I, the two syps are present in distinct complexes and do not form heteromultimers (14) .
The abundance, uniform synaptic expression, and subunit structure of syp I suggested that it may have an important function in synaptic vesicle exocytosis.. This hypothesis was supported by the following series of studies: (i) Purified syp I associates into multimers that form channels in black lipid membranes (15) . However, it is unclear if these channels represent a physiologically activated state of syp I because the disulfide bonding and subunit structure of purified syp I differed from those of native syp I. (ii) Syp I exhibited Ca2+ binding activity in a blotting assay (16) , suggesting it may be a Ca-2 sensor, although Ca2+ binding was not observed by equilibrium dialysis (17) . (iii) Injection of total mRNA from rat cerebellum into Xenopus oocytes resulted in Ca2+-dependent glutamate release that was inhibited by coinjection of syp I antisense RNA, suggesting that syp I is essential for release (18) . However, previous studies using injection of mRNA into oocytes indicated that the Ca2+-dependent neurotransmitter release observed is nonvesicular (19) . (iv) Injection of antibodies to syp I into Xenopus blastomeres inhibited transmitter secretion at neuromuscular synapses (20) . (v) Transfection of syp I into nonneuronal cells resulted in its targeting to the receptor-mediated endocytosis pathway (21) or even in the creation of a novel type of vesicles (22 (3, 24) . In the knockout vector most of the sequences between exons II and IV are replaced by a neomycin gene cassette ( Fig. 1) as a selectable marker. Embryonic stem cells were electroporated with the linearized vector and subjected to positive (0.19 g/liter of G415 on days 2-9) and negative selection (0.1 mg/liter FIAU on days 3-6). Clones were analysed for homologous recombination using PCR with oligonucleotides priming either in the neomycin resistance gene (primer D in Fig. 1 ; sequence: GAGCGCGCGCGGCGGAGTTGTTGAC) and the syp I gene outside of the knockout vector (primer C, sequence ATCTGGCAGGTAGTCCTCTCCTCA), or in the wild-type allele (primers A and B, sequences CTTCGTGAAGGTGC-TGCAGTGG and CGCACTAGTATCGATGGGTACT-CAAATTCGACTTC). Embryonic stem cell clones carrying homologously recombined syp I genes were injected into mouse blastocysts and chimeric offspring were bred, resulting in mutant mice derived from two independent homologous recombinations, one of which was analyzed in detail.
Immunoblotting and Immunocytochemistry Analysis.
SDS/PAGE was carried out as described (25) . Proteins were detected after blotting by either enhanced chemiluminescence (Amersham) or 1251-labeled secondary antibodies followed by quantitation on a Molecular Dynamics Phosphorlmager essentially as described (26, 27 XbaI; S, SpeI; X, XhoI). tions were detected using the peroxidase-antiperoxidase technique and heavy metal enhancement (26) .
Electrophysiological Recordings. Hippocampal slices (250-300 ,uM thick) were obtained from 2.5-to 4-week-old mice and whole-cell recordings were obtained from CAl pyramidal neurons as described (28) . Compound excitatory postsynaptic currents (EPSCs) were evoked by stimulating the Schaffer collateral pathway. Unitary EPSCs were evoked by extracellular stimulation of single CA3 neurons (28) . Holding potential of the CAl neuron was -70 mV. Miniature EPSCs (mEPSCs) were recorded in the presence of 1 ,uM tetrodotoxin and 0.1 mM picrotoxin and analyzed as described (29) with or without 0.5 M sucrose or 1 nM a-latrotoxin in the bath solution.
RESULTS
Structure of the Murine Syp I Gene. The murine syp I gene was cloned from a genomic 129SV library on two nonover- lapping A clones. Sequencing showed that the exon-intron structure of the murine gene was identical to that of the human gene ( Fig. 1; ref. 30 ). It is unclear if the murine or human genes contain an intron in the 5' noncoding region, but we will refer to the identified exons as exons I-VII to facilitate discussion. The 5' end of the mouse syp I mRNA as determined from the genomic sequence contains an in-frame methionine codon 18 bp upstream of the putative initiator methionine (3). This results in an extended N-terminal sequence of MLLLADM-DVVN for murine syp I that is also present in human syp 1 (30) . An interesting conserved feature of the syp I gene ( Fig. 1; ref. 30) is the presence of an intron in the 3'-untranslated region immediately 5' to an A+T-rich sequence. This results in a 3' exon, exon VII, which is entirely composed of 3'-untranslated region. The high degree of conservation of the 3'-untranslated region and of its genomic structure support the hypothesis that the A+T-rich sequence may serve as a regulatory signal.
Disruption of the Syp I Gene. A knockout vector was constructed from the genomic clones consisting of a short arm containing exons I and II, a neomycin gene cassette as a selectable marker, and a long arm containing exons IV-VII (Fig. 1) . Tlwo copies of the herpes simplex virus thymidine kinase gene were inserted to allow negative selection. Homologous recombination of this vector with the endogenous syp I gene results in a mutant gene in which exon III and large portions of introns 2 and 3 are replaced by the-neomycin gene. After electroporation of the vector into embryonic stem cells, 20% of the clones surviving positive and negative selection were found to have undergone homologous recombination (Fig. 1) . Two lines of mice carrying disrupted syp I genes were generated from independent embryonic stem cell clones, one of which was analyzed in detail.
The exon deleted by homologous recombination encodes residues 29-70 of syp I that include half of the first transmembrane region and a cysteine residue that forms a disulfide bond (5, 25) , suggesting that deletion of this exon should result in a null phenotype. This expectation was confirmed in immunoblotting experiments with a series of independent antibodies against the C terminus of syp I that failed to detect immunoreactive syp I protein. Phenotype of Syp I Deficient Mice. Mice lacking syp I did not suffer from premature morbidity or mortality as analyzed up to the age of 28 months. The mice were fertile and exhibited no significant difference in fecundity. Thus, syp I is not an essential gene. To test for more subtle changes, we studied the structure of the nervous system of the mutant mice. Macroscopically and microscopically, the brains were normal (data not shown). Antibodies against syp II, synaptotagmin I, synaptobrevin II, synaptogyrin, SNAP-25, synapsins I and II, rab3A, and rabphilin were tested by immunocytochemistry and failed to detect differences. Even for syp II, no change in distribution was observed. Syp II was found to exhibit the same heterogeneous expression in mouse brains as previously observed for rats (14) , suggesting that the expression of syp II is not subject to major changes in the syp I knockout.
Immunoblots for a series of synaptic proteins revealed no major changes in expression. Quantification of protein levels using 125I-labeled secondary antibodies showed no significant differences between wild-type and mutant mice except for synaptobrevin II. This protein [that interacts with syp I (6, 7)] exhibited a moderate statistically significant decrease (Table  1) . Together these data suggest that deficiency of syp I does not cause a major restructuring of the brain architecture or its protein composition. Synaptic Transmission in Syp I-Deficient Mice. To explore the possible effects of deleting syp I on synaptic transmission, we recorded composite EPSCs in hippocampal CAl pyramidal neurons stimulated via the Schaffer collateral/commissural pathway. The mutant mice displayed normal-size EPSCs and failed to exhibit changes in several forms of synaptic plasticity, including paired-pulse facilitation, frequency facilitation during repetitive stimulation, and long-term potentiation (Fig. 2) .
Quantal analysis of synaptic transmission between single presynaptic CA3 and postsynaptic CAl neurons also revealed no changes in synaptic function (Fig. 3) . As previously reported for rat hippocampal slices (28, 31) , stimulation of a single mouse hippocampal CA3 neuron either failed to elicit an EPSC in the CAl neuron or elicited an EPSC with an amplitude around -4 pA. Amplitude histograms of these responses displayed only two prominent peaks, one at 0 pA corresponding to transmission failures, and one at -4 pA corresponding to successful transmissions. The amplitude histograms were fitted well by the sum of two Gaussian functions and can be be interpreted in terms of the probabilistic release of a single quantum of transmitter during synaptic transmission between a given CA3 neuron and a single CAl neuron (28) .
Both the release probability (Pr, relative area under success peak) and the quantal amplitude (Qr, position of success peak)
were similar between mutant and wild-type mice. Pr was 0.50 ± 0.02 (mean ± SEM, n = 6) and 0. high levels of syp II are observed in mossy-fiber terminals but only low levels are seen at the CA3/CA1 synapses studied here physiologically (14) . Therefore (18) . This is a puzzling result since syp II is expressed in cerebellum (14) . It is possible that syp I and syp II have distinct functions or that adaptive changes may occur in the knockouts but not in the oocyte system to compensate for the deletion of syp I. Alternatively, the neurotransmitter release reconstituted in oocytes may differ from that of synapses (19) and not reflect synaptic vesicle functions.
Although it is impossible to obtain a conclusive answer to these questions at present, it seems most likely that syp I is functionally redundant with either syp II (in spite of its more heterogeneous and restricted distribution) or with with synaptogyrin [in spite of its low degree of homology (33)]. Future experiments will test these hypotheses in double and triple knockouts of syp I with syp II and/or synaptogyrin.
